In vitro T-cell functions specific to an anti-DNA idiotype and serological markers in patients with systemic lupus erythematosus (SLE). 1988

S Mendlovic, and Y Shoenfeld, and R Bakimer, and R Segal, and M Dayan, and E Mozes
Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.

The human monoclonal autoantibody 16/6 is a common anti-DNA idiotype found to have clinical relevance in patients with systemic lupus erythematosus (SLE). Therefore the ability of peripheral blood T cells of SLE patients and healthy controls to proliferate and to produce helper T-cell factors following stimulation with this idiotype was tested. It was found that T cells of 75% of healthy donors proliferated to the 16/6 idiotype, whereas only 22% of SLE patients responded to this idiotype by proliferation. On the other hand, the capability to produce T-cell helper factors specific to the 16/6 idiotype was found in a higher percentage of SLE patients (48%) as compared to healthy controls (31%). The low frequency of proliferative responses in SLE patients might be due either to the chronic exposure to the 16/6 idiotype or to the production of antiidiotype antibodies against the 16/6 idiotype, which interfere with the response to the latter stimulator.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004247 DNA A deoxyribonucleotide polymer that is the primary genetic material of all cells. Eukaryotic and prokaryotic organisms normally contain DNA in a double-stranded state, yet several important biological processes transiently involve single-stranded regions. DNA, which consists of a polysugar-phosphate backbone possessing projections of purines (adenine and guanine) and pyrimidines (thymine and cytosine), forms a double helix that is held together by hydrogen bonds between these purines and pyrimidines (adenine to thymine and guanine to cytosine). DNA, Double-Stranded,Deoxyribonucleic Acid,ds-DNA,DNA, Double Stranded,Double-Stranded DNA,ds DNA
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal

Related Publications

S Mendlovic, and Y Shoenfeld, and R Bakimer, and R Segal, and M Dayan, and E Mozes
February 1990, The Journal of rheumatology,
S Mendlovic, and Y Shoenfeld, and R Bakimer, and R Segal, and M Dayan, and E Mozes
July 1986, Journal of clinical immunology,
S Mendlovic, and Y Shoenfeld, and R Bakimer, and R Segal, and M Dayan, and E Mozes
March 1986, Clinical immunology and immunopathology,
S Mendlovic, and Y Shoenfeld, and R Bakimer, and R Segal, and M Dayan, and E Mozes
January 1991, Rheumatology international,
S Mendlovic, and Y Shoenfeld, and R Bakimer, and R Segal, and M Dayan, and E Mozes
January 1990, Critical reviews in immunology,
S Mendlovic, and Y Shoenfeld, and R Bakimer, and R Segal, and M Dayan, and E Mozes
November 1991, Clinical and experimental immunology,
S Mendlovic, and Y Shoenfeld, and R Bakimer, and R Segal, and M Dayan, and E Mozes
June 1994, Clinical and experimental immunology,
S Mendlovic, and Y Shoenfeld, and R Bakimer, and R Segal, and M Dayan, and E Mozes
April 1985, European journal of immunology,
S Mendlovic, and Y Shoenfeld, and R Bakimer, and R Segal, and M Dayan, and E Mozes
March 1987, Journal of clinical immunology,
S Mendlovic, and Y Shoenfeld, and R Bakimer, and R Segal, and M Dayan, and E Mozes
March 1984, The Journal of clinical investigation,
Copied contents to your clipboard!